These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1716458)

  • 1. Cell-binding domain of endothelial cell thrombospondin: localization to the 70-kDa core fragment and determination of binding characteristics.
    Dardik R; Lahav J
    Biochemistry; 1991 Sep; 30(38):9378-86. PubMed ID: 1716458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of human neutrophils increases thrombospondin receptor expression.
    Suchard SJ; Boxer LA; Dixit VM
    J Immunol; 1991 Jul; 147(2):651-9. PubMed ID: 1712815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation-controlled synthesis and binding of thrombospondin to granulosa cells.
    Dreyfus M; Dardik R; Suh BS; Amsterdam A; Lahav J
    Endocrinology; 1992 May; 130(5):2565-70. PubMed ID: 1374008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple domains are involved in the interaction of endothelial cell thrombospondin with fibronectin.
    Dardik R; Lahav J
    Eur J Biochem; 1989 Nov; 185(3):581-8. PubMed ID: 2512126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor.
    Taraboletti G; Belotti D; Borsotti P; Vergani V; Rusnati M; Presta M; Giavazzi R
    Cell Growth Differ; 1997 Apr; 8(4):471-9. PubMed ID: 9101093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1.
    Adams JC; Lawler J
    Mol Biol Cell; 1994 Apr; 5(4):423-37. PubMed ID: 7519904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motif), but not to the N-terminal heparin-binding region.
    Catimel B; Leung L; el Ghissasi H; Mercier N; McGregor J
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):231-6. PubMed ID: 1376110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single chain 19-kDa fragment from bovine thrombospondin binds to type V collagen and heparin.
    Takagi J; Fujisawa T; Usui T; Aoyama T; Saito Y
    J Biol Chem; 1993 Jul; 268(21):15544-9. PubMed ID: 8340381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular attachment to thrombospondin. Cooperative interactions between receptor systems.
    Asch AS; Tepler J; Silbiger S; Nachman RL
    J Biol Chem; 1991 Jan; 266(3):1740-5. PubMed ID: 1703153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor.
    Yabkowitz R; Dixit VM
    Cancer Res; 1991 Jul; 51(14):3648-56. PubMed ID: 1712244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of SVTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36.
    Li WX; Howard RJ; Leung LL
    J Biol Chem; 1993 Aug; 268(22):16179-84. PubMed ID: 7688364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of endothelial cell thrombospondin. Characterization of the heparin-binding domains.
    Dardik R; Lahav J
    Eur J Biochem; 1987 Oct; 168(2):347-55. PubMed ID: 2822410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet-osteosarcoma cell interaction.
    Clezardin P; Serre CM; Trzeciak MC; Drouin J; Delmas PD
    Cancer Res; 1991 May; 51(10):2621-7. PubMed ID: 1708697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human carcinoma cells express receptors for distinct domains of thrombospondin.
    Yabkowitz R; Dixit VM
    Cancer Res; 1991 Mar; 51(6):1645-50. PubMed ID: 1705477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of two binding domains for thrombospondin within fibronectin.
    Zafar RS; Zeng Z; Walz DA
    Arch Biochem Biophys; 1992 Sep; 297(2):271-6. PubMed ID: 1497347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of thrombospondin with endothelial cells: receptor-mediated binding and degradation.
    Murphy-Ullrich JE; Mosher DF
    J Cell Biol; 1987 Oct; 105(4):1603-11. PubMed ID: 2444599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human microvascular endothelial cells adhere to thrombospondin-1 via an RGD/CSVTCG domain independent mechanism.
    Chen ZS; Pohl J; Lawley TJ; Swerlick RA
    J Invest Dermatol; 1996 Feb; 106(2):215-20. PubMed ID: 8601718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of interaction of thrombospondin with human endothelium and inhibition of sickle erythrocyte adhesion to human endothelial cells by heparin.
    Gupta K; Gupta P; Solovey A; Hebbel RP
    Biochim Biophys Acta; 1999 Jan; 1453(1):63-73. PubMed ID: 9989246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human neutrophil adherence to thrombospondin occurs through a CD11/CD18-independent mechanism.
    Suchard SJ; Burton MJ; Dixit VM; Boxer LA
    J Immunol; 1991 Jun; 146(11):3945-52. PubMed ID: 1674522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity.
    Murphy-Ullrich JE; Gurusiddappa S; Frazier WA; Höök M
    J Biol Chem; 1993 Dec; 268(35):26784-9. PubMed ID: 8253815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.